|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,**
* A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, FIN-70211 Kuopio, Finland
Research Institute of Public Health, University of Kuopio, FIN-70211 Kuopio, Finland
Department of Medicine, University of Kuopio, FIN-70211 Kuopio, Finland
** Gene Therapy Unit, University of Kuopio, FIN-70211 Kuopio, Finland
1 To whom correspondence should be addressed. e-mail: seppo.ylaherttuala{at}uku.fi
Oxidation of LDL generates biologically active platelet-activating factor (PAF)-like phospholipid derivatives, which have potent proinflammatory activity. These products are inactivated by lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme capable of hydrolyzing PAF-like phospholipids. In this study, we generated an adenovirus (Ad) encoding human Lp-PLA2 and injected 108, 109, and 1010 plaque-forming unit doses of Adlp-PLA2 and control AdlacZ intra-arterially into rabbits to achieve overexpression of Lp-PLA2 in liver and in vivo production of Lp-PLA2-enriched LDL. As a result, LDL particles with 3-fold increased Lp-PLA2 activity were produced with the highest virus dose. Increased Lp-PLA2 activity in LDL particles decreased the degradation rate in RAW 264 macrophages after standard in vitro oxidation to 6080% compared with LDL isolated from LacZ-transduced control rabbits. The decrease was proportional to the virus dose and Lp-PLA2 activity. Lipid accumulation and foam cell formation in RAW 264 macrophages were also decreased when incubated with oxidized LDL containing the highest Lp-PLA2 activity. Inhibition of the Lp-PLA2 activity in the LDL particles led to an increase in lipid accumulation and foam cell formation.
It is concluded that increased Lp-PLA2 activity in LDL attenuates foam cell formation and decreases LDL oxidation and subsequent degradation in macrophages.
Abbreviations: Ad, adenovirus; ALAT, alanine aminotransferase; CRP, C-reactive protein; IL-6, interleukin-6; LPDS, lipoprotein-deficient serum; Lp-PLA2, lipoprotein-associated phospholipase A2; lyso-PC, lysophosphatidylcholine; oxLDL, oxidized low density lipoprotein; PAF-AH, platelet-activating factor-acetylhydrolase; pfu, plaque-forming units; SMC, smooth muscle cell; TBARS, thiobarbituric acid-reactive substance
Supplementary key words lipoprotein-associated phospholipase A2 low density lipoprotein macrophage
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives Circulation, April 22, 2008; 117(16): 2142 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kodvawala, A. B. Ghering, W. S. Davidson, and D. Y. Hui Carboxyl Ester Lipase Expression in Macrophages Increases Cholesteryl Ester Accumulation and Promotes Atherosclerosis J. Biol. Chem., November 18, 2005; 280(46): 38592 - 38598. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |